06/06/2026
New WHO guidance brings renewed attention to the urgent needs of and with (SCD).
The World Health Organization (WHO) has published its new consolidated for the management of common childhood illness: management of sickle cell disease in children and adolescents, an important publication that provides global, evidence-based guidance for improving SCD care.
This is the first WHO normative guideline dedicated to the diagnosis, prevention and clinical management of SCD in children and adolescents aged 0–19 years. Its publication is a particularly significant development for countries and health systems seeking to strengthen paediatric and adolescent SCD care, especially in settings where specialised services remain limited.
SCD is a lifelong inherited and one of the most pressing global health challenges affecting children in many parts of the world.
The guideline includes 15 across seven priority areas of care: early diagnosis, infection prevention, hydroxyurea, pain management, acute chest syndrome, stroke prevention and management, and screening for complications such as cardiopulmonary disease.
strongly encourages healthcare professionals, national health authorities, patient organisations and the wider haemoglobinopathy community to access, share and use this important WHO resource.
🔗 Read the WHO guideline in the comments section.
See less
New WHO guidance brings renewed attention to the urgent needs of and with (SCD).
The World Health Organization (WHO) has published its new consolidated for the management of common childhood illness: management of sickle cell disease in children and adolescents, an important publication that provides global, evidence-based guidance for improving SCD care.
This is the first WHO normative guideline dedicated to the diagnosis, prevention and clinical management of SCD in children and adolescents aged 0–19 years. Its publication is a particularly significant development for countries and health systems seeking to strengthen paediatric and adolescent SCD care, especially in settings where specialised services remain limited.
SCD is a lifelong inherited and one of the most pressing global health challenges affecting children in many parts of the world.
The guideline includes 15 across seven priority areas of care: early diagnosis, infection prevention, hydroxyurea, pain management, acute chest syndrome, stroke prevention and management, and screening for complications such as cardiopulmonary disease.
strongly encourages healthcare professionals, national health authorities, patient organisations and the wider haemoglobinopathy community to access, share and use this important WHO resource.
🔗 Read the WHO guideline in the comments section.
